Process Development

Sep 20, 2018
By Pharmaceutical Technology Editors
The CHF 400-million (US$416-million) investment in Lonza's biopark in Visp, Switzerland, will expand Ibex Solutions with two new offerings, drug substance development and drug substance and drug product manufacturing.
Aug 24, 2018
By Pharmaceutical Technology Editors
The new Testa Center in Uppsala, Sweden is a collaborative test bed offering biotechnology equipment from GE Healthcare for process development.
Aug 08, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
Avalon and Weill will co-develop bio-production and standardization procedures for CAR-T therapy.
Jul 19, 2018
By Pharmaceutical Technology Editors
The company has run into a snag in producing Kymriah for the diffuse large B-cell lymphoma patient population, the second indication for which the therapy was recently approved by FDA.
Jul 02, 2018
Pharmaceutical Technology
Traditional barriers between upstream and downstream bioprocessing are slowly starting to break down, as biopharma embraces more advanced analytics and process control.
Jun 08, 2018
By Pharmaceutical Technology Editors
MilliporeSigma targets emerging biotechs with US development center and global grants.
Jun 07, 2018
By Pharmaceutical Technology Editors
The company will provide the first FlexFactory manufacturing platform for TCR T-cell therapy manufacturing.
Jun 01, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
Bosch Packaging Technology will introduce its newest R&D device for continuous oral solid dosage production at Achema 2018.
May 31, 2018
By Pharmaceutical Technology Editors
Ingenza, in partnership with the University of Dundee and Drochaid Research Services, will work on a project to recycle CO2 emissions from bioprocessing plants to serve as feedstock and energy inputs.
May 30, 2018
By Pharmaceutical Technology Editors
GE Healthcare and the Centre for Commercialization of Regenerative Medicine (CCRM) will support scale-up efforts by DiscGenics for a new cell therapy intended to treat back pain.
native1_300x100
lorem ipsum